Evidence map›Paper›PMID 30284596›Full record

ArticlePsychopharmacology2019

Effects of MDPV on dopamine transporter regulation in male rats. Comparison with cocaine.

Raul Lopez-Arnau, Leticia Duart-Castells, Barbara Aster, Jorge Camarasa, Elena Escubedo, David Pubill

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Psychopharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Synthetic Cathinones and Neurotoxicity Risks: A Systematic Review.International journal of molecular sciences · 2023
    Pooled it
  2. Article
  3. Review
  4. Review
  5. Structure-Activity Relationship ofACS chemical neuroscience · 2023
    Article
  6. An updated review on synthetic cathinones.Archives of toxicology · 2021
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Raul Lopez-ArnauDepartment of Pharmacology, Toxicology and Therapeutic Chemistry, Pharmacology Section and Institute of Biomedicine (IBUB), Faculty of Pharmacy, University of Barcelona, Av. Joan XXIII, 27-31, 08028, Barcelona, Spain.
Leticia Duart-CastellsDepartment of Pharmacology, Toxicology and Therapeutic Chemistry, Pharmacology Section and Institute of Biomedicine (IBUB), Faculty of Pharmacy, University of Barcelona, Av. Joan XXIII, 27-31, 08028, Barcelona, Spain.
Barbara AsterDepartment of Pharmacology, Toxicology and Therapeutic Chemistry, Pharmacology Section and Institute of Biomedicine (IBUB), Faculty of Pharmacy, University of Barcelona, Av. Joan XXIII, 27-31, 08028, Barcelona, Spain.
Jorge CamarasaDepartment of Pharmacology, Toxicology and Therapeutic Chemistry, Pharmacology Section and Institute of Biomedicine (IBUB), Faculty of Pharmacy, University of Barcelona, Av. Joan XXIII, 27-31, 08028, Barcelona, Spain.
Elena EscubedoDepartment of Pharmacology, Toxicology and Therapeutic Chemistry, Pharmacology Section and Institute of Biomedicine (IBUB), Faculty of Pharmacy, University of Barcelona, Av. Joan XXIII, 27-31, 08028, Barcelona, Spain.
David PubillDepartment of Pharmacology, Toxicology and Therapeutic Chemistry, Pharmacology Section and Institute of Biomedicine (IBUB), Faculty of Pharmacy, University of Barcelona, Av. Joan XXIII, 27-31, 08028, Barcelona, Spain. d.pubill@ub.edu.ORCID http://orcid.org/0000-0002-6627-4501
Universitat de Barcelona · ES

Funding

Ministerio de Sanidad, Servicios Sociales e Igualdad 2014I020Ministerio de Sanidad, Servicios Sociales e Igualdad 2016I004Secretaría de Estado de Investigación, Desarrollo e Innovación SAF2016-75347R
6 · The paper itself

Abstract

rationaleMDPV (3,4-methylenedioxypyrovalerone) is a synthetic cathinone present in bath salts. It is a powerful psychostimulant and blocker of the dopamine transporter (DAT), like cocaine. It is known that acute exposure to psychostimulants induces rapid changes in DAT function.

objectivesTo investigate the effects of MDPV on DAT function comparing with cocaine.

methodsBinding of [

resultsMDPV increased surface [

conclusionsMDPV induces a rapid and reversible functional upregulation of DAT more powerfully and lasting than cocaine.

Indexed as

AnimalsBenzodioxolesCentral Nervous System StimulantsCocaineCorpus StriatumDopamine Plasma Membrane Transport ProteinsDopamine Uptake InhibitorsLocomotionMalePC12 CellsProtein BindingPyrrolidinesRatsRats, Sprague-DawleySynaptosomesSynthetic Cathinone(1R-(exo,exo))-3-(4-fluorophenyl)-8-methyl-8- azabicyclo(3.2.1)octane-2-carboxylic acid, methyl esterBenzodioxolesCentral Nervous System StimulantsCocaineDopamine Plasma Membrane Transport ProteinsDopamine Uptake InhibitorsPyrrolidinesSynthetic CathinoneBath saltsCathinonesCocaineDopamine transporterDopamine uptakeMDPVUpregulation

Identifiers

PMID30284596
OpenAlexW2895277615

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.